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Abstract 
Sulfate derived from the degradation of macromolecules is released from lysosomes via a carrier mediated process. In order to further 
characterize this process, recognized inhibitors of the erythrocyte band 3 anion transporter were examined for their effects on the 
lysosomal system. Studies with band 3 transport site inhibitors such as DIDS, SITS and phenylglyoxal indicated that, similar to the case 
for the band 3 protein, the lysosomal transporter has critical lysine and arginine residues. Band 3 translocation pathway or channel 
blocking inhibitors had mixed effects on the lysosomal system. 1,2-Cyclohexanedione, which covalently modifies a band 3 arginine 
residue distinct from that modified by phenylglyoxal, inhibited lysosomal sulfate transport. In contrast, the potent band 3 inhibitor 
dipyridamole had no effect on lysosomal sulfate transport indicating that there are some structural differences between the erythrocyte and 
lysosomal anion transporters. The band 3 translocation inhibitors niflumic acid and dinitrofluorobenzene were both effective inhibitors of 
the lysosomal system. Cupric ion inhibited sulfate transport while Ca*+, Co*+, Mg*‘, Mn*+, and Zn*’ had no inhibitory effects. 
Exposure of intact lysosomes to trypsin largely ablated transport of sulfate. This information should be useful in efforts to further 
elucidate the structure and function of the lysosomal sulfate transporter. 
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1. Introduction 
The transport of sulfate across the lysosomal membrane 
is a process that is sensitive to pH and is most active when 
sulfate is transported down a proton gradient. At pH 5.0, 
uptake of sulfate by resealed lysosomal membrane vesicles 
(pH 7.0 inside) has a K, of 160 PM and is insensitive to 
changes in membrane potential. In contrast, at pH 7.0 
uptake becomes sensitive to membrane potential. Counter- 
transport of sulfate can be demonstrated in the absence of 
a proton gradient with a t,,, of 30 s and a K, identical to 
that of uptake at pH 5.0. Competition and trans-stimula- 
tion of sulfate by other anions have been demonstrated, 
although sulfate produced by the activity of various lysoso- 
ma1 sulfatases seems to be the primary substrate for this 
system [ 11. 
Abbreviations: DIDS, 4,4’-diisothiocyanatostilbene-2,2’-disulfonic 
acid; EDTA, ethylenediaminetetraacetic acid; Hepes, 4-(2-hydroxy- 
ethyl)-l-piperazineethanesulfonic acid; Mes, 4-morpholineethanesulfonic 
acid; NAP-taurine, N-(4-azido-2-nitrophenyl)2-aminoethanesulfonic 
acid; PMSF, phenylmethylsulfonyl fluoride; SITS, 4-acetamido-4’-iso- 
thiocyanatostilbene-2,2’-disulfomc acid. 
* Corresponding author. Fax: + 1 (310) 3289921. 
A great deal of information regarding the structure and 
function of the band 3 anion protein and gene has been 
amassed [2-201, which may be useful for study of the 
lysosomal transport system. The band 3 protein has a 
molecular mass of 90 kDa and is the product of one @El) 
of a family of genes @El, AE2 and AE3) that code for 
tissue specific plasma membrane anion transporters [21]. A 
truncated transcript of the AEl gene codes for a transport 
protein with a shortened amino-terminus in rat kidney 
[22,23]. In general, a region containing the carboxyl- 
terminus of the anion transporters appears to play an 
essential role in transport and is highly conserved [24]. 
Proteins which cross react with selected anti band 3 anti- 
bodies have also been found in Golgi apparati and mito- 
chondria [25,26] while similar anion transport systems 
have been described in plasma membranes from lung 
fibroblasts and Chinese hamster ovary cells [27-291. 
The band 3 transporter shows pH dependence of anion 
transport, including increased proton-sulfate co-transport at 
low pH. At higher pH, monovalent anions such as bicar- 
bonate are recognized preferentially. Similar to the lysoso- 
ma1 system, band 3 is regulated by pH, exhibits counter- 
transport of sulfate and is sensitive to membrane potential 
at neutral pH. However, band 3 accepts monovalent anions 
0005-2736/95/$09.50 0 1995 Elsevier Science B.V. All rights reserved 
SSDI 0005-2736(94)00301-7 
80 P.J. Koetters et al. / Biochimica et Biophysics Acta 1235 (I 995) 79-84 
such as bicarbonate as substrates, while this does not 
appear to be the case for the lysosomal transporter. Band 3 
mediated anion transport is affected by three major classes 
of inhibitors that are characterized as: (1) transport site 
inhibitors, (2) translocation pathway or channel blockers, 
and (3) translocation inhibitors [30-321. Information re- 
garding the sites and mechanisms of action of these and 
other inhibitors has been useful for the development of 
models of the structure and function of the transporter. We 
have examined the effects of band 3 inhibitors on lysoso- 
ma1 sulfate transport in order to gather information regard- 
ing the structure and function of the lysosomal transport 
protein. These studies show that the lysosomal sulfate and 
band 3 anion transporters are sensitive to many of the 
same inhibitors, although differences in their responses can 
be demonstrated. 
2. Experimental procedures 
2.1. Materials 
With the exception of NAP-taurine (Pierce), all in- 
hibitors were obtained from Sigma. Na3,SO, was pur- 
chased from ICN Biochemicals, Scintiverse II (Fisher), 
Dulbecco’s phosphate-buffered saline without calcium 
(Irvine Scientific) and GFF glass fiber filters (Whatman). 
2.2. Lysosomal purification 
Female 150-200 g Sprague-Dawley rats (Harlan) were 
injected with 1000 units of heparin by tail vein just prior to 
sacrifice with CO, narcosis. The livers were removed and 
flushed of blood using ice-cold normal saline containing 1 
mM EDTA. Lysosomes were then purified from liver 
homogenates by differential centrifugation followed by 
Percoll density gradient centrifugation in the presence of 1 
mM PMSF [33]. Protein was determined spectrophotomet- 
rically [34]. 
2.3. Membrane vesicle formation 
The dense, approx. 1 ml fraction containing lysosomes 
was removed from the Percoll gradient and mixed with an 
equal volume of a buffered solution to achieve the follow- 
ing concentrations: 0.25 M sucrose, 20 mM Hepes, pH 7.0, 
2 pg/ml leupeptin, 1 pg/ml pepstatin, 500 PM PMSF, 2 
mM MgCl,, and 2.0 mg/ml bovine serum albumin. Addi- 
tion of 5 mM methionine methyl ester and incubation at 
25” C for 15 min resulted in the specific osmotic rupture of 
lysosomes. In order to prepare sulfate loaded vesicles for 
countertransport (trans-stimulation) experiments, 10 mM 
Na,SO, (final concentration) was added to the buffer 
mixture used during osmotic rupture of lysosomes by 
methionine methyl ester. The much less dense membrane 
vesicles were collected from the top of a second Percoll 
density gradient that had been prepared similarly to the 
first gradient. They were washed with 20 volumes of 0.25 
M sucrose and collected by centrifugation at 18 000 X g 
for 30 min prior to use. Vesicles prepared in this manner 
are largely free of contaminants such as plasma membrane, 
Golgi, endoplasmic reticulum, mitochondria, and internal 
hydrolases and exhibit a number of specific transport 
processes for substrates such as vitamin B,,, N-acetylglu- 
cosamine and sulfate [29,35-371. The membrane vesicles 
have a random membrane orientation and have an intraves- 
icular environment consisting of 0.25 M sucrose, 20 mM 
Hepes, pH 7.0, 2 ,ug/ml leupeptin, 1 pg/ml pepstatin, 
500 ,uM PMSF, 2 mM MgCl,, and 2.0 mg/ml bovine 
serum albumin. 
2.4. Sulfate transport 
Sulfate transport assays were conducted as previously 
described [l]. Standard assays for determination of sulfate 
uptake were performed in microcentrifuge tubes. Incuba- 
tions were initiated by the addition of 20 ~1 of membrane 
vesicles or lysosomes suspended in 0.25 M sucrose to 30 
~1 of assay buffer consisting of 0.25 M sucrose, 167 PM 
Na,SO,, 33 mM Mes, pH 5.0 with 2 &i of NaySO,. For 
determination of K, (inhibitor), the concentration of sul- 
fate in the assay buffer was varied. The tube contents were 
mixed by trituration and allowed to incubate for 1 min at 
25” C. Membrane vesicles were then collected by filtration 
through a GF/F filter and washed with 10 ml of Dul- 
becco’s phosphate-buffered saline (without calcium) at 
4” C. Filters were dried under a heat lamp and subjected to 
analysis by scintillation counting. Uptake was defined as 
pmol of sulfate/mg protein of membrane vesicles per min 
at 25” C based on the specific activity of sulfate in the 
assay buffer. 
Countertransport (trans-stimulation) assays were per- 
formed using membrane vesicles that had been previously 
loaded with sulfate as described above. Incubations were 
initiated by the addition of 20 ~1 of membrane vesicles 
suspended in 0.25 M sucrose to 30 ~1 of assay buffer 
consisting of 0.25 M sucrose, 167 /.LM Na,SO,, 33 mM 
Hepes, pH 7.0 with 2 PCi of Na;5S0,. Membrane vesicles 
were incubated, collected by filtration, washed and sub- 
jected to scintillation counting as described for sulfate 
uptake. Uptake was defined as pmol of sulfate/mg pro- 
tein of membrane vesicles per min at 25” C based on the 
specific activity of sulfate in the assay buffer. 
2.5. Kinetics 
K, was calculated by Dixon plot analysis using a 
minimum of three sulfate concentrations and a minimum 
of six points per curve at a fixed sulfate concentration. 
Sulfate concentrations ranged from O-200 PM. 
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2.6. Binding of irreversibl,e inhibitors 
Inhibition studies with phenylglyoxal and 1,2-cyclohe- 
xanedione were performed by incubating whole lysosomes 
f the appropriate inhibitor for 1 h at 37” C in 80 mM 
boric acid and 0.20 M sucrose, pH 8.0, prior to forming 
vesicles. Similar studies were performed with lysosomes 
incubated for 30 min at 37” C in 0.18 M sucrose, 50 mM 
NaCl, and 20 mM Hepes, pH 7.4 f dinitrofluorobenzene. 
In all cases, lysosomes were washed free of inhibitor prior 
to forming vesicles. 
2.7. Trypsin treatment of r’ysosomes 
Intact lysosomes were suspended in 0.25 M sucrose, 2 
mM Hepes, pH 7.0 and incubated for 10 min at 30” C with 
50 pg/ml of trypsin + 50 pg/ml soybean trypsin in- 
hibitor. Controls were incubated in the same manner f 50 
pg/ml trypsin inhibitor but without trypsin. Following 
incubation, the lysosomes were assayed for sulfate uptake. 
Latency studies were performed using the impermeant 
substrate O-P-D-galactopyranoside k 0.1% Triton X-100 
to ensure that there was no lysosomal breakage caused by 
trypsin exposure. Sample:; were incubated in 0.25 M su- 
crose, 50 mM sodium citrate, pH 5.0 for 15 min at 37” C. 
Latency was defined as 100 - (substrate hydrolysis with- 
out Triton X-loo/substrate hydrolysis with Triton X-100). 
3. Results 
3.1. Band 3 transport site inhibitors 
Consistent with our preliminary studies [l], transport 
was readily inhibited by !DIDS, an impermeant disulfonic 
acid stilbene known to injhibit band 3 function by binding 
to a specific lysine residue [8,38]. The K, for inhibition of 
lysosomal transport by DIDS was approx. 3.5 PM (Fig. 1). 
Irreversible inhibition of transport was observed in mem- 
brane vesicles which were prepared from intact lysosomes 
that were pre-incubated with DIDS suggesting that there is 
an accessible site for DIDS binding on the lysosomal 
exterior (Fig. 2). SITS, a (compound with a similar mecha- 
nism of action, also inhibited sulfate countertransport in 
membrane vesicles although the K, was somewhat higher 
at 70 PM. Phenylglyoxal, a compound known to inhibit 
band 3 transport by cov.alent modification of a specific 
arginine residue [9,39], also inhibited lysosomal anion 
transport (Table 1). These findings suggest that the lysoso- 
ma1 transporter has accessible lysine and arginine residues 
that are critical for function. In the case of the erythrocyte 
band 3 anion transporter, a lysine residue is required for 
irreversible binding of DlDS although this is not required 
for reversible inhibition by DIDS [38]. 
800 - 
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Fig. 1. Dixon plot of inhibitory effects of DIDS. Samples were prepared 
for countertransport as described in Experimental procedures, containing 
varying concentrations of inhibitor and varying concentrations of sub- 
strate (sulfate) in the incubation buffer. Membrane vesicles were exposed 
to DIDS only for the one minute assay interval. 0, 10 PM Na,SO,; ??, 
50 PM Na,SO,; and A, 100 PM Na,SO,. Each point is the mean of 
three determinations. V = pmol SOi-/mg protein per min. Ki is calcu- 
lated based on the assumption of reversible inhibition. 
3.2. Band 3 translocation pathway channel blockers 
Lysosomal sulfate transport was inhibited by 1,2- 
cyclohexanedione (Table 2) which irreversibly inhibits 
band 3 mediated anion transport by covalent modification 
of an arginine required for translocation of bound substrate 
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Fig. 2. Irreversible inhibition by DIDS. Whole lysosomes were incubated 
at pH 8.0 for 30 min at 37” C with 0.25 M sucrose, 20 mM Hepes, and 
the indicated concentrations of DIDS without sulfate. Subsequently, the 
lysosomes were washed free of any excess DID& and vesicles loaded 
with 10 mM Na2S04 were prepared for countertransport as described in 
Experimental procedures. DIDS was not added again at the time of 
countertransport. Transport was calculated as pmol SOi-/mg protein 
per min. Values represent % of control uptake from lysosomes incubated 
without DIDS. Points are means + S.D., n = 3. 
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Table 1 Table 3 
Lysosomal sulfate countertransport and band 3 transport site inhibitors 
Inhibitor Countertransport (%I K, (PM) 
Control 100 - 
25 yM DIDS 12+5 3.5 
120 PM SITS 4*2 70 
15 mM phenylglyoxal 11&8 _ 
Vesicles were prepared for assay of countertransport as described in 
Experimental procedures and incubated at 25” C for 1 min in 0.25 M 
sucrose, 20 mM Hepes, pH 7.0 with 100 /AM Na,SO,, 2 PCi of 
Nasz5S0, and the indicated inhibitors. For phenylglyoxal, membrane 
vesicles were prepared from intact lysosomes which had been incubated 
for 1 h at 37” C in 0.16 M sucrose, 80 mM boric acid, pH 8.0 with 
phenylglyoxal and then washed to remove unbound inhibitor. Results 
were compared to transport in comparably treated controls. Each value 
represents the mean + S.D., n = 3. 
Lysosomal sulfate countertransport and band 3 translocation inhibitors 
Inhibitor Countertransort (%) K, (/AM) 
Control 100 _ 
60 PM niflumic acid 13+ 2 36 
500 PM NAP-taurine 57+12 400 
1 mM dinitrofluorobenzene 3+ 2 _ 
Sulfate transport was assayed as described for Table 1. Membrane 
vesicles prepared from dinitrofluorobenzene treated lysosomes were han- 
dled as described in Table 1 for phenylglyoxal. Each value represents the 
mean + SD., n = 3. 
from the arginine modified by the transport site inhibitor 
phenylglyoxal. In contrast, dipyridamole, a potent re- 
versible inhibitor of erythrocyte band 3 transport with a K, 
of approx. 0.7 ,uM [40] had no discernable effect on 
lysosomal sulfate transport. This was observed for both 
sulfate countertransport and sulfate uptake by lysosomal 
membrane vesicles in the presence of up to 100 PM 
dipyridamole. Lysosomal membrane vesicles that were 
pre-loaded with 100 PM dipyridamole exhibited normal 
uptake of sulfate ruling out differential effects due to 
membrane orientation. In erythrocytes, inhibition of anion 
transport by dipyridamole may be dependent upon the 
presence of chloride. However, dipyridamole had no effect 
on lysosomal sulfate transport in the presence of chloride. 
Thus, unlike the case for the erythrocyte transporter, the 
lysosomal sulfate transporter is not sensitive to inhibition 
by dipyridamole. 
side) for the band 3 protein [41] also inhibited lysosomal 
sulfate transport. Similar results were obtained with 2,4-di- 
nitrofluorobenzene, an irreversible band 3 inhibitor which 
covalently modifies a lysine residue on band 3 that is 
discrete from the lysine modified by DIDS. For the band 3 
transporter, inhibition is directly related to substrate con- 
centration (chloride) presumably because dinitrophenyla- 
tion occurs during carrier translocation thus locking the 
transporter into a stable intermediate conformation [32]. 
This is a markedly different mechanism of action from 
compounds such as DIDS where available substrate can 
protect against inhibition by competing for the transport 
site. Membrane vesicles prepared from lysosomes that had 
been incubated with 2,4_dinitrofluorobenzene without 
chloride had 74 + 9% (mean f S.D., n = 3) of control 
uptake while those incubated with 2,4_dinitrofluoroben- 
zene and 50 mM chloride had 40 f 12% (mean f S.D., 
n = 3) of control uptake. This is consistent with the mech- 
anism of action proposed for the band 3 transporter (Table 
3). 
3.4. Other inhibitors 
3.3. Band 3 translocation inhibitors 
Translocation inhibitors appeared to have similar effects 
on the band 3 and lysosomal sulfate transporters. Niflumic 
acid, a reversible inhibitor of band 3 action that increases 
the free energy of formation of the rate-limiting transloca- 
tion intermediate [32], inhibited the lysosomal system with 
a K, of 36 PM. NAP-taurine, a photoreactive anion with 
K, values of 20 PM (external side) and 740 PM (internal 
The organic anion pyridoxal 5phosphate is a poorly 
transported substrate for the erythrocyte band 3 protein 
that functions as an inhibitor of transport with a K, of 860 
PM. Additional band 3 inhibitors include 2,4-dinitro- 
phenol, phloretin and phloridzin [39,42]. The mechanisms 
of action of phloretin and phloridzin are not fully defined 
although they are recognized to inhibit a variety of plasma 
membrane transport systems. All of these substances inhib- 
ited sulfate countertransport in lysosomal membrane vesi- 
cles (Table 4). 
Table 2 
Lysosomal sulfate countertransport and band 3 translocation pathway 
(channel) blockers 
Inhibitor Countertransport (%) 
Control 100 
100 FM dipyridamole 98+9 
40 mM 1,2-cyclohexanedione 10+4 
Sulfate transport was assayed as described for Table 1. Membrane 
vesicles prepared from 1,2-cyclohexanedione treated lysosomes were 
handled as described in Table 1 for phenylglyoxal. Each value represents 
the mean f S.D., n = 3. 
Table 4 
Lysosomal sulfate countertransport and miscellaneous band 3 inhibitors 
Inhibitor Countertransport (o/o) 
Control 100 
120 /AM phloretin 15f5 
3 mM phloridzin 24+8 
600 PM pyridoxal5-phosphate 65+3 
3 mM 2,4_dinitrophenol 45*3 
Lysosomal sulfate transport was assayed as described for Table 1. Each 
value represents the mean f S.D., n = 3. 
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3.5. Cations 
A variety of divalent cations were screened for their 
effects on sulfate transport. Sulfate uptake was slightly 
increased in the presence of 100 PM Ca2+, Co2+, Mg2+, 
Ni2+, and Zn2+. Transport increased by 35% with 100 
PM Mn2+. Of the divalent cations that were screened, 
only cupric ion had a significant inhibitory effect on 
transport. This effect was eliminated when the reducing 
agent, dithiothreitol was present during incubation at a 
concentration of 1 mM. The effect of cupric ion on sulfate 
uptake by membrane vesicles was similar for sulfate coun- 
tertransport by membrane vesicles and uptake by intact 
lysosomes (data not shown). 
3.6. Trypsin digestion 
Brief exposure of intact lysosomes to trypsin resulted in 
an 82% decrease in sulfate uptake for the assay interval. 
This marked inhibition ‘of uptake was completely pre- 
vented when trypsin inhibitor was present during exposure 
of lysosomes to trypsin. tncubation with trypsin inhibitor 
alone did not result in inhibition of transport. Lysosomal 
latency was not significantly affected by the exposure to 
trypsin, remaining approx. 80%. 
3.7. Inhibition and membrane orientation 
Similar to what had previously been observed in lysoso- 
ma1 membrane vesicles, pH-dependent sulfate uptake was 
demonstrated using intact Percoll density gradient purified 
lysosomes (data not shown). While lysosomal membrane 
vesicles have a random membrane orientation, intact lyso- 
somes have a uniform membrane orientation with the bulk 
of glycosylated protein on the inner surface. Results of 
inhibition studies were similar in both preparations in that 
those substances that inhibited sulfate countertransport by 
Table 5 
Inhibition of sulfate uptake in intact lysosomes 
Condition Uptake (% control) 
Control lOO+ 6 
120 /JM SITS 9+ 5 
50 /AM DIDS 1+ 1 
300 /*M dipyridamole 103 f 17 
900 PM NAP-taurine 14+ 8 
96 PM phloretin 39+11 
3 mM phloridzin 21+ 2 
600 I.LM pyridoxal S-phosphate 35* 2 
3 mM dinitrophenol 38+12 
60 PM niflumic acid 21* 4 
Intact lysosomes were incubated for 1 min at 25” C in 50 ~1 of 0.25 M 
sucrose, 20 mM Mes, pH 5.0, 100 PM Na,SO, with 1 &i of Na:‘SO,. 
Lysosomes were collected by filtration on GF/C glass fiber filters and 
washed as described for membrane vesicles. Each value represents the 
mean + S.D., n = 3. 
membrane vesicles also inhibited sulfate uptake by intact 
lysosomes (Table 5). As observed for membrane vesicles, 
dipyridamole had no effect on sulfate transport by intact 
lysosomes. Lysosomal latency was unaffected by the in- 
hibitors in the concentrations used in these experiments. 
4. Discussion 
Our studies indicate that, with one notable exception, 
lysosomal sulfate transport is sensitive to a variety of 
known inhibitors of band 3 mediated anion transport. This 
is particularly interesting because studies of band 3 have 
indicated that these inhibitors have markedly different sites 
and mechanisms of action. The inhibitory effects of SITS, 
DIDS, dinitrofluorobenzene, and pyridoxal5-phosphate all 
indicate that at least one unoccupied external lysine residue 
is critical for lysosomal sulfate transport. The effects of 
1,2-cyclohexanedione and phenylglyoxal indicate that at 
least one and possibly two arginine residues are important 
for function of the lysosomal system. Phenylglyoxal binds 
preferentially to arginine residues with relatively low pK, 
values such as are found in anion binding site of the band 
3 protein [43]. Although there is general similarity between 
inhibition of the erythrocyte band 3 anion transporter and 
the lysosomal sulfate transporter, more specific differences 
in the patterns of inhibition are apparent. For instance, 
while both proteins are inhibited by DIDS, the band 3 
protein is much more sensitive to the effects of this 
inhibitor than is the lysosomal sulfate transporter. In addi- 
tion, tryptic digestion of the cytoplasmic side of the band 3 
anion protein results in two protein fragments although the 
transporting ability of the protein is retained [44]. While 
the fragmentation pattern achieved with tryptic digestion 
of the lysosomal transporter is as yet uncertain, it is clear 
that such transport activity is greatly diminished by such 
treatment. 
Membrane orientation is a factor that must be consid- 
ered when assessing the effects of impermeant inhibitors 
on transport. Inhibition constants for impermeant com- 
pounds may vary from one side of the membrane to the 
other. For example, differential inhibition of erythrocyte 
band 3 chloride transport by DIDS and NAP-taurine is 
related to the membrane orientation of the protein [41,45]. 
Such effects are also possible for lysosomal sulfate trans- 
port since the lysosomal membrane is highly asymmetric 
as indicated by glycosylation patterns of the inner and 
outer surfaces. It is interesting to note that inhibition of 
sulfate transport by intact lysosomes is similar if not 
identical to inhibition of sulfate transport by vesicles with 
random membrane orientation. However, whether the lyso- 
somal sulfate transporter is symmetrical in its patterns of 
inhibition cannot be determined from our studies. Investi- 
gation of this issue will require the development of tech- 
niques to control the membrane orientation of vesicles 
prepared from lysosomes. 
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Most of the divalent cations that were tested had either 
no effect or were slightly stimulatory with the exception 
cupric ion which had pronounced inhibitory effects on 
transport. One possible explanation for the effect of cupric 
ion relates to its ability to interact with sulfhydryl groups. 
Although N-ethylmaleimide had no notable effect on sul- 
fate countertransport in membrane vesicles [l], it is possi- 
ble that other sulfhydryl groups are accessible to cupric 
ion. Cupric ion is also recognized for its ability to interact 
with histidine residues but the fact that dithiothreitol par- 
tially reverses the effect of cupric ion suggests that the 
effect is due to sulfhydryl interaction. Interestingly, it has 
been suggested that copper is a substrate for transport by 
the erythrocyte anion transporter [46]. Additional studies 
will be required to further explore the relationship between 
cupric ion and lysosomal sulfate transport. 
The information derived from these inhibitor studies 
indicate that the band 3 and lysosomal sulfate transporters 
have considerable functional similarities raising the possi- 
bility that these proteins may share sequence homology as 
well. Should this hypothesis prove to be correct, the 
lysosomal sulfate transporter would join the growing fam- 
ily of related proteins responsible for anion transport. 
However, the lysosomal and erythrocyte systems are clearly 
not identical as best demonstrated by their discrepant 
sensitivity to dipyridamole. Since study of inhibition is 
insufficient to resolve the nature of the relationship be- 
tween these proteins, other techniques will be required. 
Molecular characterization will be critical for more com- 
plete understanding of the structure, processing and func- 
tion of the lysosomal sulfate transporter and any possible 
relationship to the band 3 protein. 
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